Welch & Forbes’s Chemours CC Stock Holding History

Welch & Forbes’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,952	Closed	-$220K	–	368
2023 Q2	$220K	Buy	+5,952	New	+$182K	﹤0.01%	359

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Welch & Forbes's CC Position: Q3 2023 in Review

Welch & Forbes sold out of Chemours (CC) in Q3 2023, closing a stake of 5,952 shares — an estimated $220K sold.

Welch & Forbes first reported a position in CC in Q2 2023 and held it in 1 quarter. The position peaked at $220K in Q2 2023. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

Welch & Forbes reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
Welch & Forbes sold 5,952 Chemours shares in Q3 2023, an estimated $220K.
Welch & Forbes first reported a position in Chemours in Q2 2023 and held it in 1 quarter.
Welch & Forbes's Chemours position peaked at $220K in Q2 2023.
455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Welch & Forbes's 13F filing for Q3 2023, filed 3 Nov 2023.